Ceres Nanosciences
NIH Awards $129M to Nine Dx Firms for Rapid COVID-19 Diagnostics
Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.
Ceres Nanosciences Positions Nanotrap Technology for SARS-CoV-2 Testing
The company believes the reagents could boost molecular test sensitivity and prove useful in applications including extraction-free and pooled testing.
Ceres Nanosciences Gets $225K Grant to Develop Technology for Fentanyl Detection
The company's Nanotrap technology uses hydrogel nanoparticles functionalized with internal affinity baits to enrich target analytes for downstream analysis.
Lyme Disease Diagnoses Needs New Technologies, Report to Congress Says
A tick-borne disease working group recommends the federal government explore using new technologies and repurposing existing ones to improve diagnosis.
Speakers at the Next Generation Dx Summit described how lateral flow test technologies are evolving to meet POC testing challenges.